Cost: $149.99-$249.99 per month, out of pocket
Sources Diab, H., Fuquay, T., Datta, P., Bickel, U., Thompson, J., & Krutsch, K
Phase 2 clinical trials published in the New England Journal of Medicine (2023) reported substantial reductions in body weight and improvements in glycaemic control in participants with obesity and type 2 diabetes, though these findings require confirmation in larger Phase 3 studies
Visit Cookie settings to provide a controlled consent
Tirzepatide works by mimicking two hormones, glucagon-like-peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, that help your pancreas release more insulin